Skip to content

Dr. Geys Michèle

Active
Private limited companyfounded 2021active for 5 yearsPater Renaat De Vosstraat 77, 2640 Mortsel, BelgiumKBO/BCE: BE 0768.519.122
Summary

Dr. Geys Michèle has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €38,006 and a net result of €38,798. Equity has been growing by about 17% per year since 2021. Its solvency ranks better than 29% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 19-05-2021 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.317.623.572 2640 Mortsel, since 19-05-2021
Financial year end
31 December
Peppol
Reachable since 23-11-2024

Board and ownership

Board
  • Geys MichèleDirector · since 19-05-2021

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€53,787
▲ 86.3%
Turnover
≈ €120,000
estimated
Profit
€38,798
▲ 85.2%
Equity
€38,006
▼ 43.5%
Total assets
€109,438
▲ 31.4%
Filed on 24-06-2026, 37 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.53, cash €80,896Size: total assets €109,438Figures for financial year 2025 (filed on 24-06-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 42% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 60-40
equity 34.7% of total assets
Liquidity 66-28
short-term debt 64.8% · cash 73.9%
Profitability 100=
return on assets 35.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €3,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.53 (5.08 in 2024), above the usual 1.5. Short-term debt is 64.8% and cash 73.9% of total assets. However, 65.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 29% of them on solvency, 45% on liquidity, 80% on profitability and 14% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.53, cash €80,896
NBB · annual accounts
lowers risk · Size: total assets €109,438
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 24-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-06-2026, 37 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
37 days early
2024
9 days early
2023
13 days early
2022
17 days early
2021
13 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 18 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Always filed on timeaccounts within the deadline every year 5 years View
  • Positive: 5 profitable years in a rowprofit 2025: €38,798 5 years View

Recent changes

  1. · Gazette deed Incorporation
All 10 events

Comparable companies

These companies have the same main activity as Dr. Geys Michèle: general medical practice (NACE 86210). They are comparable in size and age: total assets between €102,000 and €118,000, founded between 2020 and 2022.

CompanyTotal assetsGross margin
Dr. Geys Michèle Mortsel€109,438€53,787
Manouk Lauwers Ranst€110,820€52,065
CABINET EL ASKRI Seneffe€115,143€52,510
DR. ANNE SCHUERMANS Genk€117,678€52,555
SYKLI - HUISARTS Bekkevoort€107,643€49,119
HUISARTS LIEN GERNE Lendelede€103,805€48,683
Dr. Charlotte De Vlieger Oosterzele€102,212€53,139
Full comparison

Key facts about Dr. Geys Michèle

What is the company number of Dr. Geys Michèle?
The company number of Dr. Geys Michèle is 0768.519.122. The VAT number is the same number with BE in front: BE 0768.519.122.
Where is Dr. Geys Michèle based?
The registered office is at Pater Renaat De Vosstraat 77, 2640 Mortsel.Company details
What does Dr. Geys Michèle do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Geys Michèle?
The legal form of Dr. Geys Michèle is Private limited company (BV).
When was Dr. Geys Michèle founded?
Dr. Geys Michèle was founded on 19-05-2021.
Is Dr. Geys Michèle still active?
Yes, Dr. Geys Michèle is an active enterprise in the KBO register.
What is the turnover of Dr. Geys Michèle?
The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €53,787 and 32 comparable companies (NACE 862). It probably lies between €94,000 and €160,000.Financials
Is Dr. Geys Michèle profitable?
In financial year 2025, Dr. Geys Michèle made a profit of €38,798.
Where can I find the annual accounts of Dr. Geys Michèle?
Dr. Geys Michèle filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Geys Michèle due?
Dr. Geys Michèle must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.